IT1116505B - Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico - Google Patents

Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico

Info

Publication number
IT1116505B
IT1116505B IT47717/79A IT4771779A IT1116505B IT 1116505 B IT1116505 B IT 1116505B IT 47717/79 A IT47717/79 A IT 47717/79A IT 4771779 A IT4771779 A IT 4771779A IT 1116505 B IT1116505 B IT 1116505B
Authority
IT
Italy
Prior art keywords
tutto
pharmaceutical formulation
acid based
eicosa pentaenoic
formulation acid
Prior art date
Application number
IT47717/79A
Other languages
English (en)
Italian (it)
Other versions
IT7947717A0 (it
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2357578A external-priority patent/GB1604554A/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IT7947717A0 publication Critical patent/IT7947717A0/it
Application granted granted Critical
Publication of IT1116505B publication Critical patent/IT1116505B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A23C15/126—Butter containing a minority of vegetable oils; Enrichment of butter with fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT47717/79A 1978-05-26 1979-01-19 Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico IT1116505B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2357478 1978-05-26
GB2357578A GB1604554A (en) 1978-05-26 1978-05-26 Pharmaceutical and food formulations

Publications (2)

Publication Number Publication Date
IT7947717A0 IT7947717A0 (it) 1979-01-19
IT1116505B true IT1116505B (it) 1986-02-10

Family

ID=26256599

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47717/79A IT1116505B (it) 1978-05-26 1979-01-19 Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico

Country Status (13)

Country Link
JP (1) JPS5515444A (https=)
AU (1) AU527784B2 (https=)
CA (1) CA1151068A (https=)
CH (1) CH644267A5 (https=)
DE (1) DE2831507A1 (https=)
ES (1) ES8104983A1 (https=)
FR (1) FR2426461A1 (https=)
IE (1) IE48287B1 (https=)
IL (1) IL55227A (https=)
IT (1) IT1116505B (https=)
NL (1) NL191332C (https=)
NZ (1) NZ187908A (https=)
SE (1) SE448678B (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS59172416A (ja) * 1983-03-18 1984-09-29 Terumo Corp 脂肪輸液
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
JPH0748991B2 (ja) * 1984-08-29 1995-05-31 日本油脂株式会社 経管栄養組成物
GB8710780D0 (en) * 1987-05-07 1987-06-10 Scras Opthalmological application of eicosapentaenoic acid
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
DE19503993A1 (de) * 1995-02-08 1996-08-14 Johann Friedrich Dr Med Desaga Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen
DE10056351A1 (de) * 2000-11-14 2002-05-29 Weylandt Karsten Henrich Pharmazeutisches Präparat
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
SG10201605794PA (en) 2009-04-29 2016-09-29 Amarin Pharmaceuticals Ie Ltd Stable Pharmaceutical Composition And Methods Of Using Same
EP3318255B1 (en) 2009-06-15 2021-03-10 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating stroke in a subject on concomitant statin therapy
AU2010298222B2 (en) 2009-09-23 2017-01-05 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013070735A1 (en) 2011-11-07 2013-05-16 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
ES2891473T3 (es) 2012-01-06 2022-01-28 Amarin Pharmaceuticals Ie Ltd Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto
NZ727849A (en) 2012-06-29 2018-06-29 Amarin Pharmaceuticals Ie Ltd Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
WO2014074552A2 (en) 2012-11-06 2014-05-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9975919B2 (en) 2013-02-06 2018-05-22 Agency For Science, Technology And Research Methods for reducing aggregate content in protein preparations
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
LT3750536T (lt) 2018-09-24 2026-03-25 Amarin Pharmaceuticals Ireland Limited Širdies ir kraujagyslių sistemos reiškinių rizikos subjekto organizme sumažinimo būdai
BR112022009189A2 (pt) 2019-11-12 2022-07-26 Amarin Pharmaceuticals Ie Ltd Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE319677B (https=) * 1965-03-27 1970-01-19 Sumitomo Chemical Co
FR2097036A1 (en) * 1970-07-29 1972-03-03 Sopharga Lab Lipids contg fatty acids - for treatment of atheroslerosis
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
JPS6257605A (ja) * 1985-09-05 1987-03-13 Kaizuka Kazutoshi 多元素鉱物からの有効成分抽出方法

Also Published As

Publication number Publication date
NL7904144A (nl) 1979-11-28
AU527784B2 (en) 1983-03-24
IL55227A (en) 1982-12-31
AU3808478A (en) 1980-01-17
FR2426461B1 (https=) 1983-02-11
DE2831507A1 (de) 1979-11-29
SE448678B (sv) 1987-03-16
CH644267A5 (en) 1984-07-31
IE48287B1 (en) 1984-11-28
ES480921A0 (es) 1981-05-16
NZ187908A (en) 1984-05-31
NL191332B (nl) 1995-01-02
IT7947717A0 (it) 1979-01-19
DE2831507C2 (https=) 1989-07-13
IE791023L (en) 1979-11-26
JPS5515444A (en) 1980-02-02
NL191332C (nl) 1995-06-01
SE7904570L (sv) 1979-11-27
FR2426461A1 (fr) 1979-12-21
ES8104983A1 (es) 1981-05-16
IL55227A0 (en) 1978-09-29
CA1151068A (en) 1983-08-02

Similar Documents

Publication Publication Date Title
IT1116505B (it) Formulazione farmaceutica a base di acido(tutto-z)-5,8,11,14,17-eicosa pentaenoico
NZ189574A (en) Dehydrocyclicimino acid derivatives pharmaceutical compositions
DK136579A (da) Thioetiansyrederivater
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
DK343880A (da) 2,4,6-triiod-isophthalsyrederivater
DK111179A (da) Carbaminsyrederivater
DK317178A (da) Phenyleddikesyrederivater
ES523653A0 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
GB2081715B (en) Novel 5-phenylcarbamoylbarbituric acid compounds
IT1120443B (it) Composizioni a base di acido tiazolossammico e procedimento per la loro preparazione
BR7908037A (pt) Derivados de acido fenilciclopropano-carboxilico,processos para sua producao,e composicoes acaricidas e inseticidas a base dos mesmos
IT8024157A0 (it) Ammide dell'acido poliprenilcarbossilico.
IT7928170A0 (it) Composizione farmaceutica a base di acido tiazolidin-4-carbossilico per il trattamento di malattie neoplastiche e metodi di preparazione.
IT1124842B (it) Procedimento di fabbricazione dell'acido para-idrossimandelico racemico
ES488142A0 (es) Un procedimiento para la preparacion de acido 7-metoxi-5-oxo-5h-tiazolo (2,3-b)quinazolin-2-carboxilico
IT1125480B (it) Composto a base di 2,6-diammino-nebularina
ZA792773B (en) Derivatives of 4,5-dihydro-4-oxofuran-2-carboxylic acid
IT7950715A0 (it) Composizioni farmaceutiche a basedi ariltrifluotoetanolo
ES488211A0 (es) Un procedimiento para la preparacion del acido 7-oxo-1-aza- biciclo (3.2.0)hept-2-en-2-carboxilico
IT7948749A0 (it) Medicamento a base di derivati dell'acido antranilico
AU527930B2 (en) 1,3,4-thiadiazole-2-carboxylic acid derivatives
FI790329A7 (fi) Foerfarande foer framstaellning av 1-naftylaettiksyraderivat
FI792586A7 (fi) Alfa-aminofenylaettikssyraderivat
GB2012266B (en) 1,5 - cyclohexadienecarbocylic acid derivatives
BR7905224A (pt) Processo para a preparacao de diglicidilester do acido 7-oxabiciclo(4.1.0)heptano-3,4-dicarboxilico

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960129